Current state, control, impact and management of rheumatoid arthritis according to patient: AR 2020 national survey Laly Alcaide; Antonio I. Torralba; José Eusamio Serre; Carlos García Cotarelo; Estíbaliz Loza; Francisca Sivera;

Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile Marcos Cruces Olivar; Allan D. Burboa; Yolanda M. Gómez;

Associated factors to health-related quality of life in anti-neutrophil cytoplasmic antibodies-associated vasculitis patients: Data from the Almenara Vasculitis Cohort Allison Milagros Figueroa-Sánchez; Leonor Stefani León-Yaurimucha; Manuel F. Ugarte-Gil; Victor R. Pimentel-Quiroz;